The National Information Standards Organization (NISO), a Baltimore, Maryland-based non-profit that promotes standardization in publishing, has embraced a plan to make it easier for journals to share rejected manuscripts and manuscript reviews without forcing authors to go through another arduous submission process. Read more
The analysis—which covered 486,644 biomedical articles with two to nine authors published between 1946 and 2009—found that female, black and Hispanic authors were less likely than were white men to hold prestigious last-author spots. And while all scientists tended to land more last-author spots as their careers went on, that trend was slower for women and minorities. “There’s a lack of progression for those groups,” says Bruce Weinberg, a co-author of the study and an economist at Ohio State University in Columbus. Read more
One study suggests that the concept of “brilliance” in science might discourage some women from following certain career paths or education opportunities. Another found that women are more likely than men to offer “honorary authorships” to scientists who may not or do not deserve it—a courtesy that might obscure the magnitude of their own contributions. Read more
You may have lots more to say about your discipline or field, too. Why not write a book? It isn’t easy, but it is rewarding to tell your story to a broader audience than manuscript editors and journal subscribers. And while you’re not likely to get rich from your book, you may find that it presents you with new opportunities – to raise your profile, to collaborate, to develop a novel project. Read more
Guest post from Ruedi Aebersold, Professor of Systems Biology with a joint appointment at ETH Zurich and the University of Zurich, & George Rosenberger, PhD student in the Aebersold group at the Institute of Molecular Systems Biology, ETH Zurich, on the various avenues for sharing proteomics data and the benefits of building community resources through open data
Guest post from Mark Viant, on the changes in standards and reporting for metabolomics data. Mark is Professor of Metabolomics in the School of Biosciences at the University of Birmingham, UK, and Director of both the national NERC Biomolecular Analysis Facility – Metabolomics and the Phenome Centre Birmingham. His research interests encompass the development of optimised analytical and computational workflows for high-throughput mass spectrometry based metabolomics and the application of these technologies to investigate the metabolic pathways underlying toxicity and adverse outcome pathways.